Clinical Trial Update: Efficacy and Safety of Add-On Therapy With Empagliflozin in Patients With Type 2 Diabetes on a Background of Alogliptin and Metformin [Phase 3]

View source ↗

Summary

A Phase 3 trial is evaluating add-on empagliflozin in type 2 diabetes patients already taking alogliptin and metformin; the study is currently recruiting to ass…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Alogliptin (alogliptin)
• Empagliflozin (empagliflozin)
• metformin (metformin)

Snippet

Sponsor: Celltrion | Conditions: T2DM, Diabete Type 2 | Phase 3 | Status: RECRUITING